San Jose, California (PRWEB) February 17, 2009 - Injectables represent the most vibrant and promising growth area, since downtime and recovery period is minimal to nil and costs are easy-on-the-pocket.
Surgical treatments, which provide long-term benefits, are temporality out-of-favor, especially since the US economic slowdown has tightened consumer spending on their expensive in nature, out-of-pocket surgical treatments.
Recent years have been glorious in the history of cosmetic surgery products and procedures, as new product approvals and technology improvements have strived to provide the best to the prospective patient.
Although, slightly disturbed as a result on ongoing economic meltdown, long-term forecast promise nothing but a bright future.
As the US population ages, and people have access to discretionary income, they are indeed expected to splurge on having a treatment, surgical or non-surgical.
While it is always easier to get a short of botox to smoothen wrinkles, or a dermal filler to plump up under eye hollows, demand for popular surgical treatments would continue with those for whom injections are not enough to get the desired look.
Treatments with lesser or virtually no non-surgical options such as breast augmentation leave no choice but to undergo the surgical procedure.
Surgical producers, though performed in far less numbers than non-surgical procedures, constitute the largest segment of the cosmetic surgery procedures market. Breast Augment is expected to record the fastest growth over the forecast period.
Leading growth would be non-surgical treatments. While almost all non-surgical options are expected to register healthy to above average growth, Botox will lead gains, followed by Dermal Fillers with a healthy CAGR over the forecast period.
The US cosmetic surgery products market is home to large number of companies. However, due to the diverse nature of product categories (Equipment, Injectables and Implants), not all companies are active in all market segments.
Key players include:
Palomar Medical Technologies
"Cosmetic Surgery Procedures and Products - A US & Europe Market Report" from Global Industry Analysts, Inc. analyzes the US and the European markets in Millions of US$.
The US market is analyzed in terms of both Cosmetic Surgery Products, and Cosmetic Surgery Procedures for the period 2006 through 2015.
Major Cosmetic Surgery Products analyzed for the US market include: Equipment (Lasers, Microdermabrators and Other Equipment) Injectables (Botulinum Toxin Type A, Dermal Fillers, and Other Injectables)
Implants (Breast Implants and Other Implants) and Other Markets
Cosmetic Surgery Procedures analyzed for the US market include: Surgical Breast Augmentation
Laser Hair Removal
Laser Skin Resurfacing
Microdermabrasion and Others
The European market is analyzed in terms of Cosmetic Procedures (Surgical and Non-surgical) by country for years 2008, 2010, and 2013.
Select surgical procedures analyzed for the Europe region include: Breast Augmentation
For more details about this research report, please visit
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers.
The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year.
Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com